Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

1.

Recent advances using immunomodulators for inflammatory bowel disease.

Nielsen OH, Bjerrum JT, Herfarth H, Rogler G.

J Clin Pharmacol. 2013 Jun;53(6):575-88. doi: 10.1002/jcph.2. Epub 2013 Feb 13. Review.

PMID:
23408468
[PubMed - indexed for MEDLINE]
2.

Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.

Khan KJ, Dubinsky MC, Ford AC, Ullman TA, Talley NJ, Moayyedi P.

Am J Gastroenterol. 2011 Apr;106(4):630-42. doi: 10.1038/ajg.2011.64. Epub 2011 Mar 15. Review.

PMID:
21407186
[PubMed - indexed for MEDLINE]
3.

Pharmacogenetics in inflammatory bowel disease.

Pierik M, Rutgeerts P, Vlietinck R, Vermeire S.

World J Gastroenterol. 2006 Jun 21;12(23):3657-67. Review.

PMID:
16773681
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Thiopurines in Crohn's disease, is there something new?

Miheller P, Lakatos PL.

Expert Opin Drug Metab Toxicol. 2010 Dec;6(12):1505-14. doi: 10.1517/17425255.2010.525505. Epub 2010 Oct 5. Review.

PMID:
20919963
[PubMed - indexed for MEDLINE]
5.

Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety.

Dubinsky MC.

Clin Gastroenterol Hepatol. 2004 Sep;2(9):731-43. Review.

PMID:
15354273
[PubMed - indexed for MEDLINE]
6.
7.

[Optimization of immunomodulatory treatment with azathioprine or 6-mercaptopurine in inflammatory bowel disease].

Bastida Paz G, Nos Mateu P, Aguas Peris M, Beltrán Niclós B, Rodríguez Soler M, Ponce García J.

Gastroenterol Hepatol. 2007 Nov;30(9):511-6. Spanish.

PMID:
17980127
[PubMed - indexed for MEDLINE]
8.

Medical management of patients with difficult-to-treat inflammatory bowel disease.

van Hogezand RA.

Neth J Med. 1994 Aug;45(2):55-9. Review.

PMID:
7936006
[PubMed - indexed for MEDLINE]
9.

Insights in immunomodulatory therapies for ulcerative colitis and Crohn's disease.

Nguyen GC, Harris ML, Dassopoulos T.

Curr Gastroenterol Rep. 2006 Dec;8(6):499-505. Review.

PMID:
17105689
[PubMed - indexed for MEDLINE]
11.

Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease.

Sultan K, Korelitz BI, Present D, Katz S, Sunday S, Shapira I.

Inflamm Bowel Dis. 2012 Oct;18(10):1855-8. doi: 10.1002/ibd.22866. Epub 2012 Jan 12.

PMID:
22241664
[PubMed - indexed for MEDLINE]
12.

Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.

Wahed M, Louis-Auguste JR, Baxter LM, Limdi JK, McCartney SA, Lindsay JO, Bloom SL.

Aliment Pharmacol Ther. 2009 Sep 15;30(6):614-20. doi: 10.1111/j.1365-2036.2009.04073.x. Epub 2009 Jun 23.

PMID:
19552632
[PubMed - indexed for MEDLINE]
13.

[Immunosuppressive therapy for inflammatory bowel disease: consensus by the Austrian working group on IBD].

Reinisch W, Dejaco C, Knoflach P, Petritsch W, Vogelsang H, Tilg H.

Z Gastroenterol. 2004 Sep;42(9):1033-45; discussion 1046-7. German.

PMID:
15455280
[PubMed - indexed for MEDLINE]
14.

Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease.

Desai A, Zator ZA, de Silva P, Nguyen DD, Korzenik J, Yajnik V, Ananthakrishnan AN.

Inflamm Bowel Dis. 2013 Feb;19(2):309-15. doi: 10.1002/ibd.23026.

PMID:
22605668
[PubMed - indexed for MEDLINE]
15.

Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.

Sokol H, Seksik P, Carrat F, Nion-Larmurier I, Vienne A, Beaugerie L, Cosnes J.

Gut. 2010 Oct;59(10):1363-8. doi: 10.1136/gut.2010.212712. Epub 2010 Jun 29.

PMID:
20587545
[PubMed - indexed for MEDLINE]
16.

Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study.

Flasar MH, Johnson T, Roghmann MC, Cross RK.

Inflamm Bowel Dis. 2008 Jan;14(1):13-9.

PMID:
17973305
[PubMed - indexed for MEDLINE]
17.

Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study.

Khan N, Abbas AM, Lichtenstein GR, Loftus EV Jr, Bazzano LA.

Gastroenterology. 2013 Nov;145(5):1007-1015.e3. doi: 10.1053/j.gastro.2013.07.035. Epub 2013 Jul 25.

PMID:
23891975
[PubMed - indexed for MEDLINE]
18.

Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease.

Kader HA, Wenner WJ Jr, Telega GW, Maller ES, Baldassano RN.

J Clin Gastroenterol. 2000 Jun;30(4):409-13.

PMID:
10875470
[PubMed - indexed for MEDLINE]
19.

Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.

Korelitz BI.

Gastroenterologist. 1995 Jun;3(2):141-52. Review.

PMID:
7640945
[PubMed - indexed for MEDLINE]
20.

Optimizing thiopurine therapy in inflammatory bowel disease.

Chevaux JB, Peyrin-Biroulet L, Sparrow MP.

Inflamm Bowel Dis. 2011 Jun;17(6):1428-35. doi: 10.1002/ibd.21494. Epub 2010 Oct 14. Review.

PMID:
20949566
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk